Activation of the humoral immune response in newborns’ multiple organfailure syndrome is associated with the production of interleukin-1β, whichis recognized via Toll-like receptors 2 (TLR2). The aim of this study wasto determine the role of expression of the Toll-like receptors 2 gene in thepathogenesis of newborns with multiple organ failure syndrome.A prospective observational cohort study of 149 newborns was conducted.The main group (n = 113) were newborns with multiple organ failuresyndrome, whereas the comparison group (n = 36) was newborns withoutthis syndrome. The study included analysis of the expression of the TLR2gene and its comparison with the concentration of interleukin-1β, peripheralblood lymphocyte count and clinical signs of the course of the disease.It was found that the population risk of reducing TLR2 expression was79.33% in the main group, and 27.62% in the comparison group. Increasingthe expression of the gene TLR2 in newborns leads to an increase in theconcentration of interleukin-1β, an increase in the level of peripheral bloodlymphocytes and is associated with the formation of microbial loci. Expressionreduction of the TLR2 gene may lead to the development of multiple organfailure syndrome, systemic inflammatory response syndrome, increase in thenumber of affected organs, increased frequency of involvement in the immunesystem, and the need for aggressive respiratory therapy.
___
1. WHO. Newborns: reducing mortality: Updated. 2017 [Electronic resourse].- Access mode: http://www. who.int/mediacentre/factsheets/fs333/en/.
2. Aufieri R, Picone S, Paolillo P. Multiple organ failure in the newborn. JPNIM 2014; 3(2) [Electronic resourse].- Access mode: http://www.jpnim.com/ index.php/jpnim/article/view/030254/217/.
3. Deitch EA. Gut-Origin sepsis: evolution of a concept. Surgeon 2012; 10: 350-356.
4. Hofer N, Kothari R, Morris N, Müller W, Resch B. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol 2013; 209: 542.e1-542.e11.
5. Lukens JR, Gross JM, Kanneganti T-D. IL-1 family cytokines trigger sterile inflammatory disease. Front Immunol 2012; 3: 315.
6. Kholod D, Shkurupii D, Sonnik E. Immune changes in newborn infants with gastrointestinal failure requiring intensive care. Georgian Med News 2016; 7-8: 62-66.
7. Shkurupiy D. Clinical-morphological comparisons – possible diagnostic method of multiple-organ-failure syndrome in newborns. Adv Sci J 2011; 2: 133- 135.
8. Fakih MG, Gould CV, Trautner BW, et al. Beyond infection: Device utilization ratio as a performance measure for urinary catheter harm. Infect Control Hosp Epidemiol 2016; 37: 327-333.
9. Hofer N, Müller W, Resch B. Systemic inflammatory response syndrome (SIRS) definition and correlation with early-onset bacterial infection of the newborn. Arch Dis Child Fetal Neonatal Ed 2010; 95: F151.
10. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2004; 20: 915-921.
11. Parvez Y, Mathew AG. Hyperleukocytosis in newborn: A diagnosis of concern. Indian J Hematol Blood Transfus 2014; 30(Suppl 1): 131-132.
12. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89-102.